Aclaris Therapeutics, Inc.
ACRS
DELAYED 1 MONTH

8 insider filings · Latest: Jun 4, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 5, 2026Jun 8 8:15 PMAnand MehraDirector
Option Exercise
11,580—0(D)

View →

Jun 5, 2026Jun 8 8:15 PMAndrew N SchiffDirector
Option Exercise
11,580—0(D)

View →

Jun 4, 2026Jun 8 8:15 PMAndrew N SchiffDirector
Grant/Award
53,337$4.7110,987(D)

View →

Jun 4, 2026Jun 8 8:15 PMAnand MehraDirector
Grant/Award
53,337$4.7110,987(D)

View →

Jun 5, 2026Jun 8 8:15 PMWilliam D. HumphriesDirector
Option Exercise
11,580—0(D)

View →

Jun 5, 2026Jun 8 8:15 PMChristopher P. MolineauxDirector
Option Exercise
11,580—0(D)

View →

Jun 4, 2026Jun 8 8:15 PMChristopher P. MolineauxDirector
Grant/Award
53,337$4.7110,987(D)

View →

Jun 4, 2026Jun 8 8:15 PMWilliam D. HumphriesDirector
Grant/Award
53,337$4.7110,987(D)

View →

Jun 5, 2026Jun 8 8:15 PMVincent MilanoDirector
Option Exercise
11,580—0(D)

View →

Jun 4, 2026Jun 8 8:15 PMVincent MilanoDirector
Grant/Award
53,337$4.7110,987(D)

View →

Jun 5, 2026Jun 8 8:15 PMMaxine GowenDirector
Option Exercise
11,580—0(D)

View →

Jun 4, 2026Jun 8 8:15 PMMaxine GowenDirector
Grant/Award
53,337$4.7110,987(D)

View →

May 1, 2026May 5 8:15 PMJesse Wayne HallChief Medical Officer
Option Exercise
36,375—109,125(D)

View →

Mar 1, 2026Mar 3 9:10 PMKevin BalthaserChief Financial Officer
Option Exercise
2,375—0(D)

View →